Senti Biosciences, Inc. (NASDAQ:SNTI) Shares Sold by 8Vc Gp I LLC

8Vc Gp I LLC trimmed its stake in shares of Senti Biosciences, Inc. (NASDAQ:SNTI) by 90.0% in the third quarter, Holdings Channel.com reports. The firm owned 253,755 shares of the company’s stock after selling 2,283,803 shares during the quarter. Senti Biosciences comprises approximately 0.8% of 8Vc Gp I LLC’s investment portfolio, making the stock its 2nd biggest position. 8Vc Gp I LLC owned 0.06% of Senti Biosciences worth $573,000 as of its most recent SEC filing.

Senti Biosciences Stock Down 7.7 %

SNTI opened at $2.15 on Monday. Senti Biosciences, Inc. has a twelve month low of $1.52 and a twelve month high of $7.43. The company has a fifty day moving average of $2.41 and a 200-day moving average of $2.71. The stock has a market cap of $9.85 million, a PE ratio of -0.14 and a beta of 2.74.

About Senti Biosciences

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.